STOCK TITAN
  1. Home
  2. BXRX

BXRX (BXRX) Stock Price, News & Analysis

BXRX OTC

Company Description

BXRX (OTC: BXRX) is classified in the medicinal and botanical manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for BXRX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
+13.10%

Baudax Bio Announces Corporate Update

+50.67%

Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors

clinical trial fda approval
-1.25%

Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference

conferences
+1.23%

Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

-6.55%

Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

offering
-2.63%

Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

earnings

BXRX has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, fda approval, conferences, offering, earnings. View all BXRX news →

SEC Filings

View All

No SEC filings available for BXRX.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

BXRX Company Profile & Sector Positioning

BXRX (BXRX) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.